Practice and channel partners
Physician practices, concierge groups, wellness operators, and channel partners interested in offering suPAR Bio through a compliant workflow.
Practice agreements, reseller terms, co-brand options, patient access.Partner with us
Partner with suPAR Bio.
We are evaluating partnerships that can responsibly expand access, support research, improve operations, or help introduce suPAR Bio to the right audiences.
Partner intake
Tell us what you have in mind.
Use the form for practice agreements, research conversations, lab and operations partnerships, media inquiries, events, technology platforms, investment conversations, and other collaborations.
Current status
We review partner inquiries and route them to the right internal contact before scheduling next steps.
Prefer email? Reach us at support@suparbio.com.
Partnership areas
Where collaboration usually starts.
Research and product studies
Groups interested in studying suPAR measurements alongside a product, protocol, cohort, or research question.
Research collaborations, protocol design, literature alignment, longitudinal measurement.Labs and operations
Diagnostic labs, mobile phlebotomy groups, kitting providers, logistics operators, and reagent collaborators.
Collection, processing, kitting, fulfillment, laboratory and reagent conversations.Media, events, and ambassadors
People and organizations who can help introduce suPAR Bio accurately to the right audience.
Press, podcasts, conferences, dinners, community introductions, ambassador ideas.Investment and other ideas
Investors, technology platforms, candidates, and unexpected partnership ideas that do not fit the categories above.
Capital, platform partnerships, hiring, strategic introductions, something else.Good to know
Helpful context before we talk.
LDT framework
The U.S. suPAR Bio test is offered as a Laboratory Developed Test under CLIA regulations and performed by a CLIA-certified commercial laboratory.
Ordering pathway
Testing operates through an ordering-provider pathway. We can discuss options during partner review.
Commercial model
Pricing and channel structure depend on partner type, volume, and workflow requirements.
No insurance billing
The current model is cash-pay. suPAR Bio does not bill insurance for the test.